NIVABUPA - IntraDay Trade Analysis with Live Signals

Last Updated Time : 20 Dec 25, 07:03 am

IntraDay Trade Rating: 2.2

📊 Analysis: NIVABUPA is trading at ₹75.4, below both DMA 50 (₹76.4) and DMA 200 (₹79.1), indicating short-term weakness. RSI at 47.0 shows neutral momentum, while MACD (-0.25) remains negative, suggesting bearish bias. Volume (6.25 lakh) is significantly below average (20.2 lakh), reflecting weak participation. With a very high P/E (150) compared to industry PE (42.8) and continued quarterly losses, the stock is a weak candidate for intraday trading today.

💡 Optimal Buy Price: ₹74–₹75 (only for speculative bounce trades)

🎯 Profit-Taking Exit Levels: ₹77–₹78 (short-term bounce target)

🛑 Stop-Loss / Loss Protection: ₹73 (below immediate support)

⏱️ If Already Holding: Exit intraday if price fails to sustain above ₹75 or if RSI drops below 45 with MACD continuing negative. Consider booking profits if price approaches ₹77–₹78 with volume confirmation.

✅ Positive

• 📈 Quarterly PAT improved (-₹35.3 Cr. vs -₹91.4 Cr.), showing reduced losses
• 📊 DII holding increased by 0.25%, showing domestic investor support
• 📉 Debt-to-equity ratio at 0.07 ensures financial stability

⚠️ Limitation

• 📉 Very high P/E ratio (150) compared to industry PE (42.8)
• 📊 PEG ratio at 3.33 signals poor growth-adjusted valuation
• 📉 Dividend yield at 0.00%, limiting investor appeal
• 📊 Price trading below DMA 50 and DMA 200 confirms weak trend
• 📉 Volume significantly below weekly average, showing reduced participation

🚨 Company Negative News

• 📉 Continued quarterly losses despite improvement
• 📊 FII holding reduced by -0.04%, showing foreign investor caution

🌟 Company Positive News

• 📈 Losses narrowed compared to previous quarter
• 📊 Domestic institutional investors increased stake (+0.25%)

🏭 Industry

• 📊 Industry PE at 42.8, much lower than NIVABUPA’s 150, suggesting overvaluation
• 🏥 Insurance & healthcare sector outlook tied to regulatory changes and consumer demand

📌 Conclusion

NIVABUPA is a weak intraday candidate today due to stretched valuation, bearish technicals, and continued losses. While reduced losses and DII inflows provide minor positives, momentum indicators remain weak. Traders may attempt speculative entries near ₹74–₹75 with stop-loss at ₹73 and profit booking around ₹77–₹78. Conservative traders should avoid intraday positions until fundamentals and technicals improve.

Would you like me to extend this into a peer benchmarking overlay comparing NIVABUPA with other insurance and healthcare sector stocks, so you can identify relative intraday strength opportunities?